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ABSTRACT 
 
Background: The present study aimed to evaluate the effects of different concentrations of CONPs on the OS 
status in kidney, lung, and serum of rats. Methods: Male Wistar Rats were treated intraperitoneally with 15, 30,  
and 60 mg/kg/day of CONPs. The biochemical parameters, including TAC, TTG, MDA, SOD, and CAT were assayed 
in serum, kidney, and lung tissues. Results: MDA decreased, but TTG and CAT increased in serum by the 
administration of CONPs at 15 mg/kg. In kidney homogenate obtained from the group treated with CONPs at 15 
mg/kg, TAC, TTG, and CAT significantly increased compared to the control group. However, CONPs at 15, 30, and 
60 mg/kg significantly decreased MDA level compared to the control group. In lung tissue, CONPs in doses of 15, 
30 and 60 mg/kg significantly decreased CAT activity, TTG and TAC compared to the control group, while in kidney 
tissue, CONPs at the concentrations of 30 and 60 mg/kg significantly increased MDA compared to the control 
group. Conclusion: Our findings suggest that CONPs attenuate OS in the kidney and affect the serum levels of OS-
related markers but induce OS in the lung tissue in a dose-dependent manner. 
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INTRODUCTION 
 
n the last decades, nanotechnology has developed a 
novel approach to the treatment and improvement 
of many diseases by the reduction of OS. Several 
nanoparticles such as CONPs have been designed 
for this reason
[1]
. Cerium, as a lanthanide, has a 
variety of industrial applications and has recently been 
used in nanomedicine research. CONPs consist of a 
cerium core that is surrounded by an oxygen lattice. It 
is widely employed in ultraviolet absorbents, solar 
cells, solid fuel cells, and so on
[2,3]
.   
OS means an imbalance between the production and 
degradation of free radicals and plays an important role 
in inflammation and tissue damage. The reduction of 
OS by increasing antioxidant capacity has been the best 
way for the improvement of related disorders
[4]
. 
CONPs have been reported to reduce OS and could 
scavenge ROS in vitro and in vivo
[5]
. It has also been 
shown that CONPs prevent OS injury in endothelial 
cells and reduce necrosis and apoptosis in response to 
ROS
[6]
. CONPs are able to control the cardiac, and 
kidney damage is induced by OS
[7,8]
. Guo et al.
[9]
 have 
demonstrated the protective effect of CONPs against 
OS by modulating TGF-beta signaling.  
Although many different studies mentioned above 
have confirmed the antioxidant properties of CONPs, 
some others have revealed that CONPs may induce OS 
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and tissue damage in high concentrations and low 
pH
[10]
. Besides, studies have indicated that CONPs 
produce significant OS in the lung cancer cells via the 
reduction of glutathione and alpha-tocopherol
[11]
. 
CONPs can mediate apoptosis and DNA damage 
through OS in human skin melanoma cells and induce 
OS through the p38-Nrf2 signaling pathway in the 
human bronchial epithelial cell
[12]
. 
Given the conflicting roles of CONPs, the current 
study was designed to assess the effect of different 
concentrations of CONPs on OS status in serum, lung, 
and kidney of male rats. We also determined the effect 
of CONPs on OS markers, including SOD and CAT 
activity, MDA, TAC and TTG, in serum, lung, and 
kidney.  
 
 
MATERIALS AND METHODS 
 
Reagents and chemicals 
Reagents and materials used in this study include 
Ethylene-diamine-tetra-acetic acid, Coomassie Blue, 
BSA, 2,4,6-Tripyridyl-s-triazine, DTNB, Tris base, 
hydrochloric acid, ferric chloride, and ferrous sulfate 
that all were obtained from the Sigma Chemical  
Co. (USA). The CONPs (100 nm) were purchased 
from the Neutrino Co. (Iran). The nanoparticles were 
suspended in deionized water. SOD and CAT assay 
kits were supplied from ZellBio GmbH (Ulm, 
Germany). All the other chemicals used were of the 
analytical grade.  
 
Animals’ treatment 
In total, 20 male Wistar rats (weight: 220 ± 20 g) 
were obtained from the Animal Colony of Hamadan 
University of Medical Sciences, Hamadan, Iran. The 
animals were preserved in standard conditions with a 
temperature of 22 ± 1 ºC, humidity of 45-55%, and 12-
hour light/dark cycle. The rats were ‎randomly divided 
into four groups (five animals per group). Group 1 
included healthy controls received normal saline and 
groups 2, 3, and 4 received CONPs 15, 30, and 60 
mg/kg/day intraperitoneally, respectively and 
continued for seven consecutive days. At the next 
stage, 24 hours after the last injection, the fasting rats 
were anesthetized with ketamine (50 mg/kg), and 
serum, kidney and lung samples were then collected. 
The study protocol was approved by the Medical 
Ethics Review Board of Jiroft University of Medical 
Sciences, Kerman (Code: IR.JMU.REC.1393.28). 
 
Serum and tissue perpetration 
Blood samples were collected from the heart, and 
serum was isolated quickly and kept at -20 °C. Also, 
kidney and lung tissues were excised and collected 
from all groups immediately. Tissues were then 
homogenized (10 mg of tissue in 140 mM of cold 
phosphate buffer saline, pH 7.4). The homogenate was 
centrifuged at 10,000 ×g at 4 °C for 15 minutes, and 
the supernatant was collected and maintained at  
-80 °C. 
 
Biochemical analysis 
Assay of OS parameters 
OS parameters were assayed by the ferric reducing 
ability of plasma method. This approach is based on 
the plasma ability to reduce Fe
3+
 to Fe
2+
. The reaction 
of Fe
2+
 and 2,4,6-Tripyridyl-s-triazine produces a blue 
complex with maximum absorbance at 593 nm
[13]
. To 
evaluate the plasma TTG, DTNB was used as a 
reagent. DTNB reacts with thiol molecules and creates 
a yellow complex, which has appropriate absorbance at 
412 nm in spectro-photometer
[14]
. MDA, a marker of 
lipid peroxidation, was measured by using the 
colorimetric method, which is based on a peroxidized 
lipid reaction with thiobarbituric acid. The reaction 
product was measured by using 1,1,3,3-Tetraethoxy-
propane standard curve in 532 nm
[15]
. 
 
Assessment of antioxidant enzymes activity 
CAT activity was measured using a calorimetrically 
enzymatic assay kit at 405 nm (ZellBio GmbH, Ulm, 
Germany). In this assay, the CAT activity unit was 
considered as the amount of the sample that will 
catalyze decomposition of 1 µmole of H2O2 to H2O and 
O2 in 1 minute. This method can determine CAT with 
0.5 U/mL of sensitivity. The intra- and inter-assay 
coefficient of variation was claimed to be 6.3% and 
7.9%, respectively. SOD activity was measured using a 
calorimetrically enzymatic assay kit (ZellBio GmbH, 
Ulm, Germany). In this assay, the SOD activity unit 
was considered as the amount of the sample that will 
catalyze the decomposition of 1 mmol of O2 to H2O2 
and O2 in 1 minute. The SOD activity was determined 
colorimetrically at 420 nm. 
 
Measurement of total protein  
Protein concentration in the samples was measured 
by the Bradford method using concentrated Coomassie 
blue reagent. Also, BSA was used as a standard
[13]
. 
 
Statistical analysis 
All data were expressed as mean ± SD. The results 
were analyzed by SPSS 16. Statistical analysis was 
performed using one-way analysis of variance 
(ANOVA), followed by post hoc Tukey’s test.  p < 
0.05 was considered statistically as significant level.  
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Fig. 1. Effect of CONPs treatment on TAC, TTG and MDA 
level in serum, kidney, and lung. Results are presented as means 
± SD. CONPs in doses of 15 mg/kg showed a significant 
increase in TAC level in kidney, and TTG level in serum and 
kidney, but in the CONPs 15, 30, and 60 mg/kg group, CONPs 
therapy indicated a significant decrease in TAC and TTG level 
in lung tissue, as compared with the control group (*p < 0.05). 
CONPs therapy showed a significant decrease in MDA level in 
serum (15 mg/kg) and kidney (15, 30 and 60 mg/kg) tissue 
compared with the control group. In the CONPs 30 and 60 
mg/kg group, CONPs therapy showed a significant increase in 
MDA level in lung tissue, as compared with the control group 
(*p < 0.05).  
 
RESULTS 
 
The experimental models received different doses of 
CONPs (15, 30, and 60 mg/kg) and OS biomarkers 
(TAC, TTG, and MDA levels), and CAT and SOD 
activity in serum, kidney, and lung were measured. All 
experiments repeated at least three times. 
 
OS parameters  
Serum TAC levels (Fig. 1A) showed no significant 
difference between all the groups (p > 0.05). CONPs at 
15 mg/kg caused a significant increase in the TAC 
level in kidney, but at doses of 15, 30, and 60 mg/kg, it 
decreased lung TAC level significantly, when 
compared to the control group (p < 0.05). The serum 
and kidney TTG levels in the treatment group receiving 
15 mg/kg of CONPs were higher than the control rats 
(p < 0.05). At doses of 15, 30, and 60 mg/kg, CONPs 
suppressed the TTG level in the lung compared with 
the normal groups (Fig. 1B). Based on the Figure 1C, 
treatment with CONPs (15 mg/kg) resulted in a 
significant decrease in serum MDA level compared to 
the control group. In kidney tissue, the MDA level of 
CONPs treated with three dose groups was 
significantly reduced compared to the control group (p 
< 0.05). However, in the lung tissue, CONPs at doses 
of 30 and 60 mg/kg significantly increased the MDA 
level compared with the normal rats (p < 0.05). 
 
Antioxidant enzyme activity 
According to the observations, the level of SOD 
activity between the studied groups showed no 
significant difference (p > 0.05; Fig. 2). Also, 
according to the results presented in Figure 3, serum 
and kidney CAT activity in the CONPs at 15 mg/kg 
group significantly increased (p < 0.05) compared to 
the control groups. However, in the lung, CAT activity 
in all the groups treated with CONPs significantly 
decreased compared to the control rats (p < 0.05). 
 
 
DISCUSSION 
 
Metal oxide nanoparticles such as CONPs play a 
very important role in reducing OS that occurs in 
various diseases
[16,17]
. CONPs are one of the most 
popular nanoparticles that scavenge free radicals. A 
previous study has reported that treatment with CONPs 
could reduce OS status in the tissue and serum
[18]
. 
Although there are many various studies confirming 
CONPs antioxidant properties, others have suggested 
that CONPs may increase OS and damage tissue,  
such as lung and liver, in high concentration and  
low  pH
[12,18]
.  Because  of the  high vascularity and the   
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Fig. 2. Effect of CONPs treatment on SOD level in serum, 
kidney, and lung. Results are presented as means ± SD. CONPs 
(15, 30 and 60 mg/kg) therapy showed a non-significant effect 
on SOD activity in serum, kidney, and lung tissue, as compared 
with the control group (*p < 0.05). 
 
 
possibility of nanoparticle accumulation in the lung 
and kidney, in this study, we decided to analyze the 
effect of CONPs treatment on OS factors, including 
SOD and CAT activity, MDA, TAC, and TTG 
concentration in lung, kidney, and serum. 
Our results showed that CONPs treatment increased 
TAC in kidney just with a dose of 15 mg/kg against the 
control group, significantly. Also, nanoparticle 
treatment significantly increased TTG in 15 mg/kg 
both in kidney and serum. In contrast, treatment with 
CONPs decreased TAC and TTG levels in lung tissue. 
These results support the previous evidence that 
disclosed CONPs increased total thiol and total 
antioxidant power in kidney, heart, and brain tissues 
but decreased in lung in experimental diabetic 
model
[19]
.  
In this study, CONPs decreased lipid peroxidation in 
kidney and serum, especially with a 15 mg/kg dose. 
However, treatment with CONPs resulted in the 
increased lipid peroxidation level in lung tissue in a 
dose-dependent manner. Therefore, nanoparticle 
exposure may lead to tissue damage through ROS 
production in the lung. Eom and Choi
[12]
 have 
disclosed that CONPs induce OS in bronchioles cells 
via increasing free radicals. 
According to our findings, CONP treatment did not 
have any effect on SOD activity in tissue and serum. 
These observations do not support the previous 
evidence that treatment with CONPs protect 
gastrointestinal epithelial damage against radiation 
through SOD production
[20]
. Nanoparticle exposure 
significantly elevated CAT activity in kidney and 
serum by administration of only 15 mg/kg but 
decreased CAT activity in lung, similar to other 
antioxidant parameters such as TAC and TTG. Earlier 
studies have demonstrated that CONPs reduce 
inflammation and ROS production and maintain 
enzymatic antioxidants and significantly reduce lipid 
peroxidation in the kidney
[21,22]
. According to a number 
of studies, CONPs have CAT mimetic activity that 
may be responsible for increasing CAT activity in the 
present study
[22,23]
.   
The current research revealed that the antioxidant 
effect of nanoparticle in the kidney and serum was 
dose-dependent in the rat. CONPs exert a destructive 
effect on the lung tissue and cause OS. Antioxidant 
effect of CONPs in serum and kidney has been 
approved by Chen et al.
[6] 
who showed CONPs 
prevented OS injury in endothelial cells. Pagliari  
et al.
[25]
 have also exhibited that CONPs reduce ROS-
induced cell damage in cardiac progenitor cells. 
CONPs decrease ROS level and cell damage in 
smokers through NF-κB activation, regulation of 
inflammatory genes expression, and antioxidant 
depletion
[26]
. In addition, Guo et al.
[9]
 demonstrated 
that CONPs have OS protection property by the 
modulation of TGF-beta signaling. 
Experimental data from lung tissue have been 
confirmed by recent findings. Eom and Choi
[12]
 have 
shown that CONPs produce OS in human epithelial 
cells through  p38-Nrf-2  signaling  pathway. In  
addition, CONPs can mediate apoptosis and DNA 
damage by increasing OS in human skin melanoma 
cells
[2]
. CONPs produce OS in the cells, as reflected by 
reduced  glutathione and alpha-tocopherol levels in 
human lung cancer cells
[11]
. 
In summary, the findings of the present study 
demonstrate that CONPs may attenuate intracellular 
OS  and  increase   enzymatic   antioxidant   activity  in 
 
 
           
 
 
Fig. 3. Effect of CONPs treatment on CAT activity in serum, 
kidney, and lung. Results are presented as means ± SD. In the 
CONPs 15 mg/kg group, CONPs therapy showed a significant 
increase in CAT activity in serum and kidney but in the CONPs 
15, 30, and 60 mg/kg group, CONPs therapy indicated a 
significant decrease in CAT activity in lung tissue, as compared 
with the control group (*p < 0.05). 
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serum and kidney in a dose-dependent manner. 
However, the exposure of nanoparticle in lung induces 
ROS production and decreases antioxidant factors. 
More study is needed to determine the exact molecular 
mechanism of these events.  
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